Biotech · Private company
Emerald Health Pharmaceuticals
Track this companyFree. Adds Emerald Health Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- EHP-101 25 mg BIDPhase 2 · Relapsing Forms of Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- EHP-101 25 mg ODPhase 2 · Relapsing Forms of Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- EHP-101 50 mg BIDPhase 2 · Relapsing Forms of Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- EHP-101 50 mg ODPhase 2 · Relapsing Forms of Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple SclerosisPHASE2 · SUSPENDED · started Oct 19, 2021ClinicalTrials.gov NCT04909502 · fetched Nov 12, 2026
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic SclerosisPHASE2 · SUSPENDED · started Jun 11, 2020ClinicalTrials.gov NCT04166552 · fetched Nov 12, 2026